Cargando…

Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England

BACKGROUND: England's National Institute for Health and Care Excellence (NICE) and the US’ Institute for Clinical and Economic Review (ICER) both conduct cost-effectiveness evaluations for new cancer drugs to help payers make drug coverage decisions. However, NICE and ICER assessments have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cherla, Avi, Renwick, Matthew, Jha, Ashish, Mossialos, Elias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788430/ https://www.ncbi.nlm.nih.gov/pubmed/33437948 http://dx.doi.org/10.1016/j.eclinm.2020.100625

Ejemplares similares

Cost‐Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England
por: Cherla, Avi, et al.
Publicado: (2020)

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021)

Post‐Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004–2014
por: Cherla, Avi, et al.
Publicado: (2022)

A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations
por: Srivastava, Divya, et al.
Publicado: (2023)

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
por: Simpkin, Victoria L, et al.
Publicado: (2017)

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
por: Renwick, Matthew J, et al.
Publicado: (2016)

Performance of UK National Health Service compared with other high income countries: observational study
por: Papanicolas, Irene, et al.
Publicado: (2019)

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model
por: Narendrula, Aparna, et al.
Publicado: (2023)

Racial and ethnic differences in end-of-life care in the United States: Evidence from the Health and Retirement Study (HRS)
por: Orlovic, Martina, et al.
Publicado: (2018)

Evaluation of the NHS England evidence-based interventions programme: a difference-in-difference analysis
por: Anderson, Michael, et al.
Publicado: (2023)

What is the cost of delivering routine vaccinations at GP practices in England? A comparative time-driven activity-based costing analysis
por: Crocker-Buque, Tim, et al.
Publicado: (2019)

Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales
por: Chamberlain, C, et al.
Publicado: (2014)

Older Adults in the United States Have Worse Cardiometabolic Health Compared to England
por: Pongiglione, Benedetta, et al.
Publicado: (2022)

Burden of Prescription Drug Costs in the United States
por: Curtiss, Frederic R.
Publicado: (2003)

Cost issues with telepsychiatry in the United States
por: Hilty, Donald M., et al.
Publicado: (2004)

A comparative analysis of the cost of cataract surgery abroad and in the United States
por: Camejo, Manuel David, et al.
Publicado: (2014)

Access, quality, and costs of care at physician owned hospitals in the United States: observational study
por: Blumenthal, Daniel M, et al.
Publicado: (2015)

The Cost of Cardiac Rehabilitation Services in England and Wales
por: Gray, Alastair M, et al.
Publicado: (1997)

Disentangling the Cost of Orphan Drugs Marketed in the United States
por: Althobaiti, Hana, et al.
Publicado: (2023)

Structural equation model for estimating risk factors in type 2 diabetes mellitus in a Middle Eastern setting: evidence from the STEPS Qatar
por: Roman-Urrestarazu, Andres, et al.
Publicado: (2016)

The origin of cost–benefit analysis: a comparative view of France and the United States
por: Jiang, Wei, et al.
Publicado: (2021)

Comparing cancer drug approval systems in the United States and Japan
por: Kaneda, Yudai, et al.
Publicado: (2023)

Comparison of Opioid Prescribing by Dentists in the United States and England
por: Suda, Katie J., et al.
Publicado: (2019)

Penile cancer treatment costs in England
por: Keeping, Sam T., et al.
Publicado: (2015)

The costs of dementia in England
por: Wittenberg, Raphael, et al.
Publicado: (2019)

Parental migration and self-reported health status of adolescents in China: A cross-sectional study
por: Lu, Weijia, et al.
Publicado: (2020)

Cognitive health among older adults in the United States and in England
por: Langa, Kenneth M, et al.
Publicado: (2009)

1951 Influenza Epidemic, England and Wales, Canada, and the United States
por: Viboud, Cécile, et al.
Publicado: (2006)

Financing Approaches to Social Prescribing Programs in England and the United States
por: SANDHU, SAHIL, et al.
Publicado: (2022)

Bending the cost curve in the United States: the role of comparative effectiveness research
por: Ghaferi, Amir A
Publicado: (2010)

Clinical outcomes and costs of cardiac revascularisation in England and New York state
por: Leyva, Francisco, et al.
Publicado: (2018)

Assessing the Costs of Screening for Ovarian Cancer in the United States: An Evolving Analysis
por: Gorski, Justin W., et al.
Publicado: (2020)

Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment
por: Butler, Eboneé N., et al.
Publicado: (2020)

Comparing loneliness in England and the United States, 2014–2016: Differential item functioning and risk factor prevalence and impact
por: Hawkley, Louise C., et al.
Publicado: (2020)

The Cost of Hyperkalemia in the United States
por: Betts, Keith A., et al.
Publicado: (2017)

The Effect of the COVID-19 Pandemic on Digital Health–Seeking Behavior: Big Data Interrupted Time-Series Analysis of Google Trends
por: van Kessel, Robin, et al.
Publicado: (2023)

Prescribing patterns and costs associated with erectile dysfunction drugs in England: a time trend analysis
por: Bell, Colette, et al.
Publicado: (2021)

Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
por: Fabiano, G., et al.
Publicado: (2022)

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

Spatial dynamics of the 1918 influenza pandemic in England, Wales and the United States
por: Eggo, Rosalind M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9fr78vpls00ov3ehcligk91me5